The present invention provides peptides, compositions and methods for treatment and alleviation of lysosomal storage diseases and their diagnosis and treatment, including Gauchers Disease, and particularly which utilize one or more progranulin (PGRN) derivative or fragment, particularly fragment ND7/Pcgin.